{"id":"https://openalex.org/W4393166262","doi":"https://doi.org/10.1016/j.esmoop.2024.102788","title":"215TiP A phase II study of durvalumab (MEDI 4736) maintenance in frail limited disease small cell lung cancer patients after thoracic chemo-radiotherapy (CRT): DURVALUNG trial","display_name":"215TiP A phase II study of durvalumab (MEDI 4736) maintenance in frail limited disease small cell lung cancer patients after thoracic chemo-radiotherapy (CRT): DURVALUNG trial","alternate_titles":[],"publication_year":2024,"publication_date":"2024-03-01","ids":{"openalex":"https://openalex.org/W4393166262","doi":"https://doi.org/10.1016/j.esmoop.2024.102788"},"language":"en","primary_location":{"id":"doi:10.1016/j.esmoop.2024.102788","doi":"https://doi.org/10.1016/j.esmoop.2024.102788","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2024.102788","pdf_url":null,"source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4393166262"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.esmoop.2024.102788","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081676975","display_name":"\u00c9lisa Gobbini","orcid":"https://orcid.org/0000-0002-0555-5836","observed_orcids":["https://orcid.org/0000-0002-0555-5836"]},"institutions":[{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E. Gobbini","raw_affiliation_strings":["Thoracic Oncology Department, Institut Curie, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Oncology Department, Institut Curie, Paris, France","institution_ids":["https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003424696","display_name":"Thomas Filleron","orcid":"https://orcid.org/0000-0003-0724-0659","observed_orcids":["https://orcid.org/0000-0003-0724-0659"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]},{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T. Filleron","raw_affiliation_strings":["Haute Garonne, Institut Claudius Regaud - IUCT Oncopole, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haute Garonne, Institut Claudius Regaud - IUCT Oncopole, Toulouse, France","institution_ids":["https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011222163","display_name":"S. Thureau","orcid":"https://orcid.org/0000-0001-5772-2336","observed_orcids":["https://orcid.org/0000-0001-5772-2336"]},"institutions":[{"id":"https://openalex.org/I4387152093","display_name":"Centre Henri Becquerel","ror":"https://ror.org/00whhby07","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210141925","https://openalex.org/I4387152093"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Thureau","raw_affiliation_strings":["Centre Henri Becquerel, Rouen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Henri Becquerel, Rouen, France","institution_ids":["https://openalex.org/I4387152093"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053842558","display_name":"Lionel Falchero","orcid":"https://orcid.org/0000-0002-3459-2767","observed_orcids":["https://orcid.org/0000-0002-3459-2767"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L. Falchero","raw_affiliation_strings":["Service de Pneumologie et Canc\u00e9rologie Thoracique, L'Hopital Nord Ouest - Villefranche-Sur-Saone, Villefranche-Sur-Saone, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de Pneumologie et Canc\u00e9rologie Thoracique, L'Hopital Nord Ouest - Villefranche-Sur-Saone, Villefranche-Sur-Saone, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040336299","display_name":"Jacques henri Le Treut","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109141","display_name":"H\u00f4pital Europ\u00e9en","ror":"https://ror.org/01tfhsg94","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210109141"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Le Treut","raw_affiliation_strings":["Pneumology, H\u00f4pital Europ\u00e9en Marseille, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pneumology, H\u00f4pital Europ\u00e9en Marseille, Marseille, France","institution_ids":["https://openalex.org/I4210109141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048837449","display_name":"R\u00e9mi Bonetto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107854","display_name":"H\u00f4pital priv\u00e9 Clairval","ror":"https://ror.org/01tt80y42","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210107854"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. Bonetto","raw_affiliation_strings":["Bouches du Rhone, Hopital Priv\u00e9 Clairval - Ramsay Sant\u00e9, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bouches du Rhone, Hopital Priv\u00e9 Clairval - Ramsay Sant\u00e9, Marseille, France","institution_ids":["https://openalex.org/I4210107854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063587973","display_name":"M. Bernardi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107251","display_name":"Centre Hospitalier Intercommunal Aix-Pertuis","ror":"https://ror.org/01txxxh71","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210107251"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Bernardi","raw_affiliation_strings":["Maladies Respiratoires, CH du Pays d'Aix, Aix-en-Provence, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maladies Respiratoires, CH du Pays d'Aix, Aix-en-Provence, France","institution_ids":["https://openalex.org/I4210107251"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080306425","display_name":"S. Benyoub","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107251","display_name":"Centre Hospitalier Intercommunal Aix-Pertuis","ror":"https://ror.org/01txxxh71","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210107251"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Benyoub","raw_affiliation_strings":["Centre de Radioth\u00e9rapie du Pays d'Aix, Aix-en-Provence, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre de Radioth\u00e9rapie du Pays d'Aix, Aix-en-Provence, France","institution_ids":["https://openalex.org/I4210107251"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003120857","display_name":"Louis Stoffa\u00ebs","orcid":"https://orcid.org/0000-0001-9259-0076","observed_orcids":["https://orcid.org/0000-0001-9259-0076"]},"institutions":[{"id":"https://openalex.org/I4210150365","display_name":"Institut Paoli-Calmettes","ror":"https://ror.org/04s3t1g37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210150365"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L. Stoffaes","raw_affiliation_strings":["Oncologie M\u00e9dicale 2, IPC - Institut Paoli-Calmettes, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncologie M\u00e9dicale 2, IPC - Institut Paoli-Calmettes, Marseille, France","institution_ids":["https://openalex.org/I4210150365"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082777483","display_name":"Clotilde Simon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141925","display_name":"UniCancer Group","ror":"https://ror.org/04vhgtv41","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. Simon","raw_affiliation_strings":["Research & Development Department, Unicancer, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development Department, Unicancer, Paris, France","institution_ids":["https://openalex.org/I4210141925"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022892812","display_name":"Assia Lamrani-Ghaouti","orcid":"https://orcid.org/0000-0002-1022-0280","observed_orcids":["https://orcid.org/0000-0002-1022-0280"]},"institutions":[{"id":"https://openalex.org/I4210141925","display_name":"UniCancer Group","ror":"https://ror.org/04vhgtv41","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Lamrani-Ghaouti","raw_affiliation_strings":["Research & Development Department, Unicancer, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development Department, Unicancer, Paris, France","institution_ids":["https://openalex.org/I4210141925"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050800572","display_name":"J. Doyen","orcid":"https://orcid.org/0000-0003-4646-4778","observed_orcids":["https://orcid.org/0000-0003-4646-4778"]},"institutions":[{"id":"https://openalex.org/I4210151846","display_name":"Centre Antoine Lacassagne","ror":"https://ror.org/05hmfw828","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210151846"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Doyen","raw_affiliation_strings":["Centre Anticancer Antoine Lacassagne, Nice, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Anticancer Antoine Lacassagne, Nice, France","institution_ids":["https://openalex.org/I4210151846"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3730,"currency":"USD","value_usd":3730},"apc_paid":{"value":3730,"currency":"USD","value_usd":3730},"fwci":0.1438,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.38723485,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":92},"biblio":{"volume":"9","issue":null,"first_page":"102788","last_page":"102788"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":0.8799999952316284},{"id":"https://openalex.org/keywords/limited-stage-small-cell-lung-cancer","display_name":"limited-stage small cell lung cancer","score":0.8889999985694885},{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":0.9890000224113464},{"id":"https://openalex.org/keywords/maintenance-immunotherapy","display_name":"maintenance immunotherapy","score":0.8889999985694885},{"id":"https://openalex.org/keywords/vulnerable-patients","display_name":"vulnerable patients","score":0.7950000166893005},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7139999866485596},{"id":"https://openalex.org/keywords/prophylactic-cranial-irradiation","display_name":"prophylactic cranial irradiation","score":0.8669999837875366},{"id":"https://openalex.org/keywords/sarcopenia","display_name":"sarcopenia","score":0.6759999990463257},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.6890000104904175},{"id":"https://openalex.org/keywords/toxicity","display_name":"toxicity","score":0.47600001096725464},{"id":"https://openalex.org/keywords/ecog-performance-status","display_name":"ECOG performance status","score":0.7360000014305115},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.460999995470047}],"concepts":[{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.9745360612869263},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6899665594100952},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.6815376281738281},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.48775988817214966},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47230198979377747},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4477868676185608},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4465637803077698},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.3416138291358948},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29520827531814575},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.1276938021183014},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.esmoop.2024.102788","doi":"https://doi.org/10.1016/j.esmoop.2024.102788","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2024.102788","pdf_url":null,"source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.esmoop.2024.102788","doi":"https://doi.org/10.1016/j.esmoop.2024.102788","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2024.102788","pdf_url":null,"source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7136077002","https://openalex.org/W4225166206","https://openalex.org/W2997099970","https://openalex.org/W2939111270","https://openalex.org/W7162636342","https://openalex.org/W4402722875","https://openalex.org/W4415520149","https://openalex.org/W7162632649","https://openalex.org/W4405315483","https://openalex.org/W7171540704"],"abstract_inverted_index":{"Small":[0],"cell":[1],"Lung":[2],"Cancer":[3],"(SCLC)":[4],"is":[5,37,49,81,122,251],"a":[6,24,68,74,148,175,275],"rare":[7],"tumour":[8],"subtype,":[9],"and":[10,30,43,64,144,157,167,294,317,323,326],"approximately":[11],"one":[12],"third":[13],"of":[14,34,62,73,104,215,260,292,304,313],"the":[15,60,102,142,155,213,223,233,239,243,254,308,311,318],"SCLC":[16,54],"patients":[17],"(pts)":[18],"present":[19],"limited":[20,51],"disease":[21,149],"(LD-SCLC)":[22],"with":[23,41,279],"5-year":[25],"survival":[26,256,324],"rate":[27],"between":[28,320],"20%":[29],"25%.":[31],"The":[32,71,248,269],"standard":[33],"care":[35],"(SOC)":[36],"platinum-based":[38],"chemotherapy":[39],"combined":[40],"etoposide":[42],"thoracic":[44],"radiotherapy":[45,65,321],"(CRT).":[46],"While":[47],"immunotherapy":[48,63,78],"currently":[50,83],"to":[52,100,179,185,206,252,267,301],"advanced":[53],"setting,":[55],"NSCLC":[56],"setting":[57],"suggest":[58],"that":[59],"combination":[61],"may":[66],"produce":[67],"synergistic":[69],"effect.":[70],"relevance":[72],"multimodal":[75],"strategy":[76],"including":[77],"after":[79,154,212,232],"CRT":[80,143,156,177],"therefore":[82],"under":[84],"investigation,":[85],"but":[86],"frail":[87,109,134,159],"LD-SCLC":[88,110,135,261],"pts":[89,111,218,236,262],"are":[90,286],"often":[91],"excluded":[92],"from":[93,307],"clinical":[94,305],"trials.":[95],"Thus,":[96],"DURVALUNG":[97,121],"study":[98],"aims":[99],"evaluate":[101,253],"efficacy":[103],"durvalumab":[105,187,264,309],"maintenance":[106],"specifically":[107],"in":[108,131,222],"who":[112],"have":[113],"not":[114,173],"progressed":[115],"following":[116],"concomitant":[117,176],"or":[118,152,171,194],"sequential":[119],"CRT.":[120,216],"an":[123],"academically-lead,":[124],"open-label,":[125],"multicentre,":[126],"randomized":[127,183,221],"phase":[128],"II":[129],"trial":[130],"previously":[132],"untreated":[133],"pts.":[136],"Pts":[137],"will":[138,181,202,219,229,273,298],"be":[139,182,203,220,230,274,299],"screened":[140],"during":[141],"only":[145],"those":[146],"achieving":[147],"control":[150],"(SD":[151],"PR/CR)":[153],"presenting":[158],"condition":[160],"(ECOG":[161],"PS":[162,165],"2,":[163],"ECOG":[164],"0-1":[166],"older":[168],"than":[169],"70":[170],"did":[172],"receive":[174,186],"due":[178],"comorbidities)":[180],"1:1":[184],"every":[188],"4":[189],"weeks":[190],"for":[191,242],"24":[192],"months":[193],"surveillance":[195],"as":[196],"per":[197,258],"SOC.":[198],"Prophylactic":[199],"Cranial":[200],"Irradiation":[201],"allowed":[204],"according":[205],"local":[207],"SOC":[208],"within":[209],"45":[210],"days":[211],"end":[214],"110":[217],"study.":[224],"A":[225],"safety":[226],"interim":[227],"analysis":[228,272,278],"performed":[231],"first":[234],"15":[235],"included":[237],"into":[238],"experimental":[240],"arm":[241,265],"Data":[244],"Safety":[245],"Monitoring":[246],"Board.":[247],"main":[249],"objective":[250],"progression-free":[255],"(PFS),":[257],"investigator,":[259],"on":[263,315],"compared":[266],"surveillance.":[268],"primary":[270],"endpoint":[271],"Cox":[276],"regression":[277],"90%":[280],"confidence":[281],"interval":[282],"(1-sided).":[283],"Secondary":[284],"objectives":[285],"BIRC":[287],"PFS,":[288],"overall":[289],"survival,":[290],"quality":[291],"life,":[293],"toxicity.":[295],"Ancillary":[296],"studies":[297],"conducted":[300],"determine":[302],"biomarkers":[303],"benefit":[306],"maintenance,":[310],"impact":[312],"sarcopenia":[314],"outcomes,":[316],"correlation":[319],"plan":[322],"outcomes":[325],"toxicities.":[327],"EudraCT:":[328],"2021-005920-39":[329],"NCT05617963.":[330],"Unicancer.":[331],"AstraZeneca.":[332]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4393166262","counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2024-03-26T00:00:00"}
